Lockheed Q3 profit surge and raised outlook bolster missile story, but segment details still critical

What happened

Lockheed Martin reported Q3 2026 net income of $1.85 billion, or $7.97 per share, up from $1.62 billion, or $6.95 per share, a year earlier, and raised its full-year outlook as backlog reached a record. This headline improvement aligns with the missile-demand thesis outlined in the master report, but the report cautioned that backlog growth had been concentrated in the THAAD program while Aeronautics faced fixed-price charges. The raised outlook suggests management expects continued strength, yet it remains unclear whether the increase reflects funded PAC-3 awards and broad-based missile volume or remains dependent on a single large contract. Without segment-level details, the profit jump could still mask persistent execution issues in aircraft programs, which would undermine the sustainability of the earnings beat. Investors should await the 10-Q filing for confirmation that MFC margin held above 14% and that no new F-16 or C-130 charges emerged.

Implication

The raised outlook and record backlog reinforce revenue visibility, but the stock's valuation at roughly 21 times earnings leaves little room for disappointment. Investors should watch for three catalysts: funded PAC-3 awards under FY2026 appropriations, sustained MFC margin above 14%, and no new Aeronautics profit adjustments. If those conditions are met in the upcoming 10-Q, the stock could justify its premium and potentially move higher; if not, the current price may already discount too much. Given the uncertainty, maintain the previous discipline: trim positions above $650 and consider adding only near $545. Until the specifics are clear, a wait-and-see approach remains appropriate.

Thesis delta

The investment thesis has not materially changed; the WAIT rating and conviction of 2.5 remain appropriate given the stock's valuation. Strong Q3 results reduce near-term execution risk, but the core uncertainty around PAC-3 funding and Aeronautics margin stability persists. Until the 10-Q confirms broad-based improvement, we maintain our cautious stance.